Register or Sign in
to unlock feature

you are not authorized to read this article.

Login or register your account to get full access to the tableting technology platform.

Login Register
Please verify your account
Please confirm your email address to validate your registration. Follow the link on email received to verify your email adress.
Re-send verification email
Please complete your registration
You're logged in but you didn't complete your registration.
Complete my registration
Exclusive content

You are not authorized to read this article.

mystylone subscription is required to view this content.

Login Register
Close search
  • Resources
  • Products & Services
    • Compaction Simulators
    • R&D / Process Support
  • Events
  • About
  • Contact Us
  • Sign in
Resources
  1. Home /
  2. Resources /
  3. Newsfeeds /
  4. The effect of compression pressure on the first layer surface roughness and delamination of Metformin and Evogliptin bilayer and trilayer tablets
NEWSFEEDS

The effect of compression pressure on the first layer surface roughness and delamination of Metformin and Evogliptin bilayer and trilayer tablets

December 18, 2023
Remove from favorites
Add to favorites

The study aimed to assess the delamination of convex-shaped tablets containing metformin HCl (MF) and evogliptin tartrate (EG) based on pre-compression and main compression pressures. Simultaneously, the study sought to establish correlations with surface roughness analysis. Granules of free-flowing MF and EG (with median diameters of 38.3 μm and 44.7 μm, respectively) were prepared using the wet granulation method. These granules underwent pre-compression and were subsequently compressed into bilayer and trilayer tablets using a universal testing machine.

The study observed a linear increase in the compaction force required to break the tablets as the main compression pressure rose within the range of 30–150 MPa. Conversely, the interfacial strength and compaction breaking force decreased with an increase in the pre-compression pressure, ranging from 10 to 110 MPa. A surface roughness analysis utilizing a profilometer revealed a significant decrease in the roughness of the first layer (MF) from 5.89 to 0.51 μm (Ra) as the pre-compression pressure increased from 10 to 150 MPa in the bilayer tablet.

This reduction in the roughness of the first layer resulted in diminished inter-penetration at the interface, as confirmed by energy dispersive spectrometer (EDS)-equipped scanning electron microscopy. This decrease in interfacial bonding strength led to the delamination of the MF/EG multi-layer tablets. The study highlights the importance of controlling roughness in the actual preparation of multi-layer tablets and underscores the utility of profilometer- and EDS-based surface analyses for interpreting delamination in such tablets.

More information
Tablet_Multilayer_15_HD.original
simulator newsfeeds compaction
Contributor(s):
Share Copied!
Comments

No comments posted yet.

Add a comment

Articles you may like

Image MEDELPHARM STYL'One Nano for early-stage characterization

STYL’One Nano R&D compaction simulator for early-stage material characterization and development

first_published_at:June 13, 2024, 10 a.m. / date_published:None
Newsfeeds - 13/06/2024 -
The MEDELPHARM STYL’One Nano is a compact and advanced compaction simulator designed for early-stage tablet formulation in research and development. It helps researchers address formulation challenges in tablet and oral …

STYL'One Nano-DMU tabletting school-Sixtine

Leveraging the STYL'One Nano compaction simulator for educational purposes

first_published_at:July 11, 2024, 11:37 a.m. / date_published:None
Newsfeeds - 11/07/2024 -
In the rapidly evolving field of pharmaceutical sciences, innovative tools and technologies are essential to advancing research and development. One such innovative instrument is the STYL'One Nano, offered by MEDELPHARM. …

MEDELPHARM_CPHI_Nano_Demonstration

MEDELPHARM and Armor Pharma collaborate for innovative formulation development at CPHI 2024

first_published_at:Oct. 3, 2024, 9:41 a.m. / date_published:None
Newsfeeds - 03/10/2024 -
MEDELPHARM is excited to announce its participation at CPHI 2024 in Milan, exhibiting in collaboration with Armor Pharma, a leading manufacturer of pharmaceutical excipients. Together, they will present live demonstrations …

More

Related products

Take_off_sensor

Linear ejection device

MEDELPHARM
Introducing the linear ejection device, a versatile accessory designed to seamlessly integrate with the STYL'One …
STYL'One Evo WipCon® - 2

Continuous liner

MEDELPHARM
The entry of powder in the compression zone of a compaction simulator is a critical …
rapid transfer port 2-small

Rapid transfer port (RTP)

MEDELPHARM
The entry of powder in the compression zone of a compaction simulator is a critical …
Pass-Through Box 1

Pass-through Box

MEDELPHARM
The entry of powder in the compression zone of a compaction simulator is a critical …
STYL'One Nano scientist powder zoom

On-site training program - STYL'One Nano

This 1-day program, conducted in your laboratory, incorporates classroom concepts, hands-on instruction, and interactive workshops …
STYL'One Nano scientist

In-house training program - STYL'One Nano

This 1.5-day program, conducted at MEDELPHARM Science Lab in Lyon or KORSCH INNOVATION CENTERs in …
Evolution_resize

STYL'One Evo

MEDELPHARM
The STYL’One Evo is a highly versatile compaction simulator designed to support pharmaceutical and nutraceutical …
0.STYLOne_Nano_y66g4Pc_resize

STYL'One Nano

MEDELPHARM
The STYL’One Nano is a compact, benchtop compaction simulator designed for early-stage tablet formulation and …
STYLOne_EVO_OEB3_sans_fond_mod_resize

STYL'One Evo DryCon®

MEDELPHARM
The STYL’One Evo is designed to work under negative pressure and as such, the standard …
STYLONE_EVO_OEB5_transparent_apxkk5N_resize

STYL'One Evo WipCon®

MEDELPHARM
The STYL’One Evo is designed to work under negative pressure and as such, the standard …
laptop laboratory gloves

Looking for additional information?

Let us help you

Contact our experts

GENERAL

  • Terms of service
  • Privacy Policy
  • Cookie Policy
  • About
  • Contact us

Account

  • Login

Follow us on

© 2025 Medelpharm